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Abstract Mitochondria, the main site of cellular energy
harvesting, are derived from proteobacteria that evolved
within our cells in endosymbiosis. Mitochondria retained
vestiges of their proteobacterial genome, the circular mito-
chondrial DNA, which encodes 13 subunits of the oxidative
phosphorylation multiprotein complexes in the electron
transport chain (ETC), while the remaining *80 ETC
components are encoded in the nuclear DNA (nDNA). A
further *1,400 proteins, which are essential for mitochon-
drial function are also encoded in nDNA. Thus, a majority of
mitochondrial proteins are translated in the cytoplasm, then
imported, processed, and assembled in the mitochondria. An
intricate protein quality control (PQC) network, constituted
of chaperones and proteases that refold or degrade defective
proteins, maintains mitochondrial proteostasis and ensures
the cell and organism health. The mitochondrial unfolded
protein response is a relatively recently discovered PQC
pathway, which senses the proteostatic disturbances specif-
ically in the mitochondria and resolves the stress by retro-
grade signaling to the nucleus and consequent transcriptional
activation of protective genes. This PQC system does not
only transiently resolve the local stress but also can have
long-lasting effects on whole body metabolism, fitness, and
longevity. A delicate tuning of its activation levels might
constitute a treatment of various diseases, such as metabolic
diseases, cancer, and neurodegenerative disorders.
Introduction
Mitochondria play a crucial role in the overall homeostasis
of the cell. Mitochondria accommodate the enzymatic
machinery capable of ATP production by oxidative phos-
phorylation (OXPHOS) and are the prime site of metabolic
processing in unicellular organisms, plants, and animals. As
mitochondria evolved from endosymbiotic a-proteobacteria
residing in the eukaryotic cell, they retained the vestiges of
the circular bacterial DNA encoding for 13 proteins and
contain several proteins with strong similarities to bacterial
proteins (Wallin 1993). Most of the *1,500 mitochondrial
proteins are, however, encoded by the nucleus and imported
post-translationally by means of a specialized and highly
conserved machinery (Chacinska et al. 2009; Neupert and
Herrmann 2007; Schmidt et al. 2010).
In the past years, this unique organelle received an
increasing interest from the scientific community, as
researchers have highlighted the implication of mitochondrial
dysfunction in the aging process and in common diseases such
as cancer, diabetes, and diverse neurological disorders
(Nunnari and Suomalainen 2012). Within this context, it is of
particular interest to investigate the mechanisms that ensure
optimal function of mitochondria. Here, we give a brief
overview of mitochondrial quality control systems, with a
particular focus on the mitochondrial unfolded protein
response (UPRmt) and its implications in animal physiology.
Mitochondrial quality control systems
As the mitochondrial proteome is continuously challenged
by multiple factors, mitochondria have evolved an elabo-
rate protein quality control (PQC) system that maintains
proteostasis and mitochondrial function in response to
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various levels of proteotoxic damage (Fischer et al. 2012;
Friedman and Nunnari 2014; Rugarli and Langer 2012).
Almost all mitochondrial proteins are transcribed and
translated in the cytoplasm. They have to be imported through
the double membrane of the mitochondria in their unfolded
state, before they are folded and assembled within the mito-
chondria (Harbauer et al. 2014; Schmidt et al. 2010). As most
electron transport chain (ETC) complexes are composed of
subunits encoded by both the nuclear and mitochondrial
genomes, they have to be present in well-defined stochio-
metrical ratios. A number of essential housekeeping proteins
assist in processes, such as protein import, folding, and su-
percomplex assembly. Among these proteins, chaperones of
the heat shock protein (Hsp) family, such as mtHsp70, Hsp10,
or Hsp60, fold the newly imported proteins or refold damaged
proteins. Proteases such as HtrA2, Yme1l in the mitochondrial
intermembrane space (IMS) and ClpP or Lon in the matrix
furthermore guarantee the degradation of proteins that are
irreversibly damaged. Several antioxidant enzymes indirectly
contribute to the maintenance of proteostasis by clearing ROS.
Mitochondria do not behave as a multitude of isolated
organelles but are rather a connected and cooperative
network that undergoes constant remodeling (Friedman and
Nunnari 2014). The dynamics of the mitochondrial net-
work is regulated by proteins such as MFN1/2, OPA1 and
DRP1, Mff, MiD49/51 that mediate fusion and fission,
respectively (Andreux et al. 2013; Jin and Youle 2013;
Loson et al. 2013). Fusion of healthy mitochondria to
mitochondria harboring damaged components constitutes a
beneficial replacement and/or dilution process (Chan
2012). Alternatively, fission promotes the segregation of
dysfunctional mitochondria, favoring their subsequent
elimination through mitophagy, governed among others by
PINK1 and Parkin (Youle and van der Bliek 2012).
Depending on the level of damage, those mechanisms are
gradually triggered to repair or eliminate mitochondrial
proteins or mitochondrial units. In case of irreversible
insults to the mitochondria that are beyond repair and
hence jeopardize cellular survival, apoptosis will ensue
(Friedman and Nunnari 2014; Martinou and Youle 2011).
As most of the PQC proteins are encoded in the nucleus,
the state of mitochondrial health has to be communicated
to the nucleus, in order to specifically adapt the PQC to
proteostatic needs. The general term ‘‘retrograde signal-
ing’’ defines all mitochondrial cues sent to the nucleus to
respond to variations in the organelle homeostasis (Liu and
Butow 2006; Ryan and Hoogenraad 2007).
Mitochondria-to-nucleus signaling of the UPRmt
Accumulation of unfolded proteins leading to protein
aggregation represents a dangerous threat not only for a
specific subcellular compartment but also for the rest of the
cell. Chaperones assist protein folding and assembly and
thus ensure proteostasis in the cell (Hartl et al. 2011). Pro-
teotoxic stress, which exceeds the protein folding capacity
by chaperones, is sensed and transduced to the nucleus to
induce the transcription of genes implicated in proteostatic
surveillance, a mechanism termed ‘‘unfolded protein
response’’. Heat was among the first identified stresses dis-
rupting the protein folding homeostasis, which contributed
to the name ‘‘heat shock proteins’’ of many chaperones
(Richter et al. 2010). Specific responses to a proteotoxic
stress occurring in specific subcellular compartments,
namely cytosol, endoplasmic reticulum (ER), and mito-
chondria, have been described. In the cytosol, proteostasis is
ensured by the heat shock factor (HSF) transcription factor
family, which, among others, regulates Hsp70 and Hsp90
expression, whereas protein misfolding in the ER is assessed
by the transmembrane proteins inositol-requiring 1 (IRE-1),
activating transcription factor 6 (ATF6) and protein-like
endoplasmic reticulum kinase (PERK), culminating with the
induction of chaperones as BiP (GRP-78) (Buchberger et al.
2010; Mori 2009; Walter and Ron 2011).
The UPRmt has been rather recently identified. In
monkey COS-7 cells, overexpression of a mutant, aggre-
gation-prone form of the mitochondrial protein ornithine
transcarbamylase (OTC) triggered the accumulation of
unfolded proteins in the mitochondria (Zhao et al. 2002).
This led to an increase in mRNA and protein levels of
Hsp60, Hsp10, the protease ClpP and the Hsp40 family
chaperone mtDNAJ. Although initially discovered in
mammalian cells, the molecular mechanism of this path-
way has been more extensively characterized in the nem-
atode C. elegans. Furthermore some studies in Drosophila
and very recently in yeast have focused on the UPRmt. This
paragraph summarizes the UPRmt signaling in those model
systems, from the triggering stimuli initiating the mito-
chondria-to-nucleus signaling to the consequences on glo-
bal protein synthesis.
Triggering the UPRmt
Any stress affecting proteostasis within the mitochondria,
such as heat, could potentially activate the mitochondrial
chaperones (Zhao et al. 2002). However, selective pertur-
bations in the mitochondria enable a proper study of the
UPRmt per se and specifically induce mitochondrial target
proteins without affecting the expression of ER and cyto-
plasmic chaperones. The artificial accumulation of unfol-
ded proteins was achieved by overexpression of mutant
OTC in mammalian cells and in the Drosophila (Pimenta
de Castro et al. 2012; Zhao et al. 2002). In C. elegans, the
knock-down (KD) by RNAi feeding of mitochondrial
proteases, such as spg-7, or mitochondrial chaperones, as
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hsp-6 and hsp-60 (orthologs of mtHsp70 and Hsp60 in
mammals, respectively), strongly induces the UPRmt
(Yoneda et al. 2004). As these proteins are essential
components of PQC, impairment of either of them is suf-
ficient to destabilize organelle proteostasis and trigger the
UPRmt. The same effect can be observed by interfering
with expression of prohibitin, a mitochondrial inner
membrane complex that supervises ETC assembly, as
reduced prohibitin levels result in active UPRmt in C. ele-
gans as well as in yeast (Schleit et al. 2013; Yoneda et al.
2004). Exposing cells to toxic compounds, such as the ROS
inducer paraquat, which subsequently increases protein
damage, also activates the UPRmt (Yoneda et al. 2004).
Proteostasis is also challenged when missing or reduced
expression of ETC subunits impedes the stoichiometry and/or
assembly of the multiprotein OXPHOS complexes. Loss of
function of mrps-5, a mitochondrial ribosomal protein (MRPs),
or of other MRPs, potently activates the UPRmt, as impaired
mitochondrial protein translation decreases the production of
mitochondrial-encoded ETC subunits and results in an increased
load of unassembled orphan ETC subunits encoded by the
nucleus (Houtkooper et al. 2013). Our laboratory termed this
concept ‘‘mito-nuclear protein imbalance,’’ which also occurs
after knock-down of ETC subunits in the worm and in Dro-
sophila (Durieux et al. 2011; Owusu-Ansah et al. 2013). Phar-
macologically, doxycycline or chloramphenicol can reproduce
this effect in the mouse and in the worm, as these antibiotics
affect not only bacterial, but also mitochondrial translation,
given that mitochondria are derived from bacterial ancestors
(Houtkooper et al. 2013). Ethidium bromide, which causes a
selective loss of the mitochondrial DNA (mtDNA) (and hence
mitochondrial protein production), also leads to mito-nuclear
protein imbalance, activating the UPRmt in both the worm and
mammalian cells (Martinus et al. 1996; Yoneda et al. 2004).
Interestingly, rapamycin, which inhibits cytosolic trans-
lation through inhibition of TOR signaling (Zid et al. 2009),
also induces a mito-nuclear imbalance and the UPRmt, but in
this case by generating an excess of orphan mitochondrial-
encoded ETC subunits (Houtkooper et al. 2013). In a similar
fashion, several pharmacological treatments enhancing
mitochondrial biogenesis, such as resveratrol or the activa-
tion of the worm sirtuin sir-2.1 by nicotinamide riboside
(NR) or by PARP inhibitors, as well as sir-2.1 overexpres-
sion, also trigger the UPRmt (Mouchiroud et al. 2013b). It is,
therefore, apparent that the ratio between nuclear and mito-
chondrial ETC subunits and not their absolute levels is the
predominant factor that causes mito-nuclear imbalance and
triggers the UPRmt.
Transcriptional regulation of the UPRmt
In C. elegans, the generation of reporter worm strains
expressing GFP under the control of the promoter of either
hsp-6 or hsp-60 (known as hsp-6::GFP and hsp-60::GFP
strains) (Yoneda et al. 2004) greatly facilitated the study of
the mitochondrial stress response at the transcriptional level.
The use of these strains for RNAi-based screens enabled the
detailed characterization of the signaling components
upstream of the transcriptional response (Benedetti et al.
2006; Haynes et al. 2007, 2010). ubl-5, a gene encoding for a
ubiquitin-like protein, was found to be required for the
proper activation of these reporters during the UPRmt and for
subsistence of the worms with stressed mitochondria
(Benedetti et al. 2006). The UPRmt enhances UBL-5 levels
and its nuclear localization, suggesting that it acts as a stress-
responsive transcriptional regulator (Fig. 1). Similarly, in
later screenings, the bZIP family transcription factors atfs-1
and dve-1 were described as essential nuclear signaling
components of the UPRmt (Haynes et al. 2007, 2010). All
three factors translocate to the nucleus upon mitochondrial
stress. DVE-1 furthermore is reported to form a dimer with
UBL-5, which together with ATFS-1 activates the tran-
scription of the UPRmt genes (Haynes et al. 2010). However,
how the folding stress is communicated to those nuclear
players has not yet been fully characterized. clpp-1, a mito-
chondrial matrix protease, proved to be essential for ubl-5
induction, DVE-1 relocalization, and activation of the
UPRmt response (Haynes et al. 2007). The exact role of clpp-
1 was revealed when the peptide efflux achieved by the inner
membrane transporter HAF-1 was identified as a pivotal
event in the signaling (Haynes et al. 2010). The model thus
suggests that clpp-1 digests excess unfolded proteins in
proteotoxic stress conditions. The resulting peptide frag-
ments, which are transported to the cytosol by HAF-1, lead to
the activation of the nuclear players DVE-1, UBL-5 and
ATFS-1, ultimately inducing the reparative transcriptional
response (Fig. 1).
Interestingly, in the absence of stress, ATFS-1 is
imported into the mitochondria due to a mitochondrial
targeting sequence (MTS) present at its N-terminus. Once
within the mitochondria, ATFS-1 is constitutively degra-
ded by the Lon protease (Nargund et al. 2012). However,
ATFS-1 also contains a nuclear localization signal (NLS).
During mitochondrial stress, the mitochondrial import of
ATFS-1 is reduced, ATFS-1 will accumulate in the
nucleus, facilitating the activation of the downstream
adaptive events that characterize the UPRmt response.
These findings clarified the part of the role of HAF-1 in
signaling of the UPRmt, as this transporter was shown to
reduce the import of ATFS-1 under mitochondrial stress
conditions (Nargund et al. 2012).
In the mammals, fewer players in the UPRmt signaling
have been identified. The main transcription factor impli-
cated in the mammalian UPRmt is CHOP, which hetero-
dimerizes with C/EBPb upon overexpression of mutant
OTC (Fig. 2). As a result, the CHOP/C/EBPb dimer binds


























Fig. 1 UPRmt signaling pathway in C. elegans. Unfolded proteins,
accumulating in the mitochondria, are digested by the protease CLPP-
1 into short peptides. These peptides are exported into the cytoplasm
through a transporter HAF-1 and by a yet unknown mechanism,
inhibit mitochondrial import. Impairment of the import allows the
nuclear translocation of transcription factor ATFS-1, which, in non-
stress conditions, moves into the mitochondria and is degraded by
protease LONP-1. ATFS-1, together with other nuclear factors UBL-5
and DVE-1 activate the protective UPRmt target genes, which
reconstitute the mitochondrial proteostasis. In parallel to ATFS-1
mediated transcriptional response, ROS, produced by stressed mito-
chondria, activate the kinase GCN-2, which phosphorylates eIF2a,
which leads to down-regulation of global translation and thus reduces








































Fig. 2 UPRmt signaling in mammals in the matrix and intermem-
brane space (IMS). Accumulation of unfolded proteins in the
mitochondrial matrix leads to activation of JNK2, which triggers
c-Jun binding to AP-1 elements to up-regulate CHOP and C/EBPb
transcription. Dimer of CHOP and C/EBPb transcription factors binds
to specific UPRmt promoter element and activates the target genes.
Additionally, PKR decreases global translation rate by phosphorylat-
ing eIF2a, and mitochondrial import is attenuated by down-regulation
of TIM17A. Under proteotoxic stress in mitochondrial IMS, increased
levels of unfolded proteins and ROS trigger activation of AKT, which
phosphorylates ERa. Activated ERa upregulates the transcription of
PQC protease OMI, which restores IMS proteostasis
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to and activates the promoters of the UPRmt responsive
genes (Horibe and Hoogenraad 2007; Zhao et al. 2002).
Although CHOP is also known to mediate the UPRER
(Schroder 2006), its specificity to the UPRmt might reside
in the fact that both the CHOP and C/EBPb promoters
contain an AP1 site that is required for their induction upon
mitochondrial stress but not upon UPRER (Horibe and
Hoogenraad 2007). The AP1 site is bound by the c-Jun
transcription factor, which is regulated by JNK2. Promoter
analysis of the UPRmt responsive genes revealed that they
contain a CHOP-binding site flanked by two mitochondrial
unfolded protein response elements (MURE) (Aldridge
et al. 2007). Among the 11 genes, containing the MUREs
and up-regulated upon mutant OTC expression are chap-
erones Hsp60, Hsp10, mtDnaJ (Hsp40 family), proteases
ClpP and YME1L1, the import complex subunit Tim17A,
and mitochondrial enzymes, such as thioredoxin 2 (Trx2),
cytochrome C reductase, endonuclease G, and NDUFB2.
Interestingly, the folding capacity of the mitochondrial
IMS can be specifically affected by the overexpression of a
mutant form of the IMS located endonuclease G (Radke
et al. 2008). This triggers a different stress response, acti-
vating other genes than those of the ‘‘canonical’’ mito-
chondrial matrix UPRmt, such as the IMS protease OMI
and the proteasome. Unliganded estrogen receptor a (ERa)
mediates this IMS-UPR in a manner dependent on ROS
generation and activation of AKT signaling (Papa and
Germain 2011).
Effects of the UPRmt on translation and mitochondrial
protein import
Besides the induction of transcriptional targets of UPRmt
targets, other mechanisms aimed at restoring proteostasis
and mitochondrial integrity occur in the course of the
UPRmt. Notably, the further generation of new mitochon-
drial proteins is reduced by impeding global protein syn-
thesis in the cytosol (Baker et al. 2012). During
mitochondrial stress conditions in the worm, general con-
trol non-derepressible-2 kinase (GCN-2) phosphorylates
translation initiation factor eIF2a in a ROS-dependent
manner and thus slows down cytosolic translation (Baker
et al. 2012). GCN-2 and ATFS-1 effects are dissociable,
and they signal in different arms of the UPRmt. Similarly,
dsRNA-activated protein kinase (PKR) mediates phos-
phorylation of eIF2a, thus attenuating protein translation in
the cytosol during the UPRmt in mammals (Rath et al.
2012). These findings link the UPRmt to the integrated
stress response (ISR), a pathway comprising kinases that
act negatively on translation through eIF2a phosphoryla-
tion following oxidative stress, ER stress, viral infections,
and other cellular attacks (Wek and Cavener 2007; Wek
et al. 2006).
In addition to stalling of the protein synthesis upon
mitochondrial stress, the import of new mitochondrial
proteins is also affected, in order to limit the load of pro-
teins to be folded within mitochondria. In HEK293 cells
treated with arsenite (As(III)), induction of the ISR
decreases total protein levels of the TIM17A subunit of the
mitochondrial protein import complex TIM23, by
increasing its degradation and repressing its translation
(Aldridge et al. 2007; Rainbolt et al. 2013). Conversely,
when import is artificially repressed by the knock-down of
TIM23 subunits in HEK293 cells and in C. elegans, the
UPRmt is activated in an haf-1/atfs-1-dependent manner in
the worm, enhancing also its resistance to paraquat
(Rainbolt et al. 2013). The importance of mitochondrial
import regulation is also evident in C. elegans, as a general
decrease of mitochondrial import is required for ATFS-1
nuclear translocation and consequent activation of tran-
scriptional program of the UPRmt (Nargund et al. 2012). Of
note is the fact that in mammalian cells, transcription of
TIM17A gene was shown to be induced as a target of the
UPRmt due to the presence of MURE sites in its promoter,
indicating a recovery of mitochondrial import upon reso-
lution of the stress (Aldridge et al. 2007).
Physiological implications of the UPRmt
Extension of lifespan and cell-non-autonomous
signaling of the UPRmt
Studies of the effects of the UPRmt on whole body
metabolism and overall fitness have started in simple
model organisms such as C. elegans and D. melanogaster;
however, recent studies suggest that the UPRmt may have a
similar important role in mammals.
KD of ETC components in C. elegans reduces devel-
opmental rates and body size. Interestingly, this also leads
to a robust extension of lifespan (Dillin et al. 2002). A
simple interpretation, coherent with the ‘‘ROS theory of
aging’’ (Harman 1956), would attribute the increased life-
span to the reduced respiration rates, which leads to gen-
eration of less ROS byproducts. However, later studies
identified UPRmt activation as causative for the lifespan
extension after ETC disruption, as exemplified by the
longevity of the cytochrome c oxidase cco-1 mutant
(Durieux et al. 2011). Similarly, a study in Drosophila
showed that mild perturbation of the ETC in muscle has
positive effects on muscle function, locomotor activity, and
lifespan due to UPRmt activation (Owusu-Ansah et al.
2013). More recently, our laboratory established that the
UPRmt subsequent to the presence of a mito-nuclear
imbalance also robustly extends worm lifespan (Houtko-
oper et al. 2013). In line with these findings, low expression
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of mouse Mrps5 (or other MRPs) triggers the UPRmt and
correlates with a long lifespan in the BXD mice genetic
reference population, demonstrating the evolutionary con-
servation of this mechanism in mammals (Argmann et al.
2005; Peirce et al., 2004). Mito-nuclear imbalance also
contributes to the lifespan extension driven by the activa-
tion of C. elegans sirtuin, sir-2.1 (Mouchiroud et al.
2013b). Pharmacological or genetic manipulations leading
to NAD? accumulation or enhanced sir-2.1 expression
levels in C. elegans boost mitochondrial metabolism,
induce mito-nuclear imbalance, and activate the UPRmt,
which in parallel to an antioxidant program leads to a
significant lifespan extension (Mouchiroud et al. 2013a).
There are temporal and spatial requirements for UPRmt
activation, in order for it to have beneficial effects on
lifespan. In C. elegans, UPRmt induction by RNAi against
cco-1 or mrps-5 only during the larval stage is sufficient to
ensure a lasting effect on lifespan (Dillin et al. 2002;
Durieux et al. 2011). Conversely, cco-1 or mrps-5 RNAi
starting in adulthood is neither able to activate the UPRmt
nor impact on longevity (Dillin et al. 2002). In addition to
the prerequisite of a specific time frame, only mitochon-
drial stress in selected worm tissues, i.e., intestine and
neurons, but not muscle, can extend longevity (Durieux
et al. 2011). Interestingly, perturbations of the mitochon-
drial homeostasis in one tissue can be sensed and com-
municated to other tissues by cell-non-autonomous cues
that were termed ‘‘mitokines.’’ Knocking down the sig-
naling component ubl-5 selectively in neurons can block
this inter-tissue UPRmt signal, suggesting that the retro-
grade signaling arm is required only in the tissue emitting
the mitokine (Durieux et al. 2011). In D. melanogaster,
ImpL2, the ortholog of the Insulin binding protein 7 (IG-
FBP7) that is secreted in response to KD of ETC compo-
nents in the muscle, participates in the organismal
adaptation to mitochondrial perturbation and mediates
lifespan extension (Owusu-Ansah et al. 2013). Interest-
ingly, in human patients with mitochondrial myopathy due
to ETC deficiencies, the cytokine FGF-21 was shown to be
secreted from muscle tissue suggesting that the ETC dys-
function may mimic fasting and induce the release of the
fasting hormone FGF-21 (Suomalainen et al. 2011). This
muscle release of FGF-21 drives inter-organ communica-
tion that results in enhanced ketogenesis in the liver and
lipid mobilization from the fat, suggesting FGF-21 to be a
human mitokine (Suomalainen et al. 2011). In another
study, interference with autophagy and the resulting
mitochondrial dysfunction in mice also led to the secretion
of the Fgf21 mitokine (Kim et al. 2013). Interestingly, the
ISR was implicated in this response, as loss of autophagy
led to phosphorylation of eIF2a and increased the expres-
sion of activating transcription factor 4 (Atf4). In this
context, Fgf21 secretion improved insulin sensitivity and
protected mice from obesity, although the direct link with
the UPRmt has not yet been examined (Kim et al. 2013).
UPRmt-induced mitohormesis
UPRmt activation upon mitochondrial stress is intrinsically
linked to a certain level of mitochondrial dysfunction,
questioning what is the balance between harmful and
beneficial effects of the UPRmt. If the mitochondrial insult
is mild, the adaptive stress response that ensues can over-
come the initial insult and have a beneficial, long-lasting
impact. This phenomenon resembles the concept of ‘‘mi-
tohormesis’’ caused by ROS (Ristow and Zarse 2010).
Treatment with low doses of inducers of oxidative stress,
such as paraquat, generates low levels of ROS and the
resulting adaptive response extends lifespan, whereas
treatment with high doses resulting in excessive levels of
ROS is toxic (Ristow and Zarse 2010). However, in the
case of cco-1 (Durieux et al. 2011) or mrps-5 (Houtkooper
et al. 2013) RNAi in the developing worm, ROS does not
play a role in the lifespan extension, hence representing a
unique case of mitohormesis only driven by the UPRmt.
Whereas the UPRmt improves the fitness of an organism
and extends its lifespan, if the level of stress inflicted to the
mitochondria is too high, the ensuing UPRmt might be
insufficient to counteract the damage inflicted, and hence
an adaptive response will turn into a detrimental response.
This explains why worms exhibit a shortened lifespan after
hsp-6 RNAi (Haynes et al. 2007), although the UPRmt is
strongly activated by this genetic manipulation (Yoneda
et al. 2004). Similarly, in the fly, overexpression of a
mutant OTC protein negatively impacts on lifespan and
phenocopies mutations in PINK1 and Parkin (Pimenta de
Castro et al. 2012), as it causes a too severe level of
mitochondrial dysfunction. Interestingly, the UPRmt and
the mitophagy quality control systems were recently found
to be triggered concomitantly, as PINK1 recruitment on the
mitochondrial membrane was enhanced by accumulation
of unfolded proteins in the mitochondria, as well as by the
knock-down of the LONP1 protease, showing that these
responses are connected to some degree (Jin and Youle
2013).
This mitohormetic action of the UPRmt is well illus-
trated in a recent report in yeast (Schleit et al. 2013).
Although dietary restriction (DR) has been shown to extend
lifespan in diverse species (Kennedy et al. 2007), the effect
of DR is highly dependent on the genotype of the organism.
Among the yeast strains presenting the highest increase of
replicative lifespan upon DR, is the Dphb2 strain, a mutant
of a subunit of the prohibitin complex (Schleit et al. 2013).
KD of prohibitin in yeast activates the UPRmt, as also
observed in C. elegans (Yoneda et al. 2004). Interestingly,
Dphb2 mutation improves lifespan only in the context of
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DR, while in nutrient-rich medium, it shortens the lifespan.
The difference between these two conditions is that a
general reduction of translation rates occurs upon DR,
which attenuates the UPRmt (Schleit et al. 2013). Thus, DR
lowers the mitochondrial stress to a level, which enables
the positive effects of mitohormesis mediated by UPRmt
activation. Similarly, phb-2 RNAi strongly activates the
UPRmt and shortens lifespan in wild type worms, while in
mutant worms with reduced translation rates, the UPRmt is
induced to a lower extent, leading to longevity (Schleit
et al. 2013). These observations suggest that slowing-down
the translation rate might be beneficial in some cases of
mitochondrial dysfunction associated with high UPRmt
activation. This mechanism could have interesting thera-
peutic implications that warrant further study.
Implications of the UPRmt in disease
As increased UPRmt can be both beneficial and harmful,
depending on the level of the UPRmt, it is conceivable that it
can be either a cause or a potential treatment strategy for dis-
ease. Although there are no studies as of yet that show the direct
implication of the UPRmt in disease, several reports suggest
that the UPRmt may be linked to a specific set of disorders.
Metabolism and diabetes
As discussed above, impaired prohibitin function activates
the UPRmt in several model systems (Schleit et al. 2013;
Yoneda et al. 2004). In the mouse, a pancreatic b-cell-
specific knockout of Phb2 contributes to progressive
development of diabetes due to b-cell dysfunction (Supale
et al. 2013). Although Opa1 proteolysis and impaired
mitochondrial dynamics were identified as potential
mechanisms behind the b-cell dysfunction, it will be
interesting to test, to which extent the activation of the
UPRmt could contribute or inversely limit the pathogenesis
of diabetes in this context.
Also linked to diabetes and metabolic disease, the
hypothalamic knockout of Hsp60 revealed an implication
of this chaperone in the development of insulin resistance
(Kleinridders et al. 2013). Expression of Hsp60 in hypo-
thalamus was shown to be dependent on leptin. As insulin
and leptin resistance are known to be linked, this may
explain why diabetic patients have decreased HSP60 levels
in the brain. Loss of Hsp60 by itself causes mitochondrial
dysfunction and ROS overproduction and consequently
leads to hypothalamic insulin resistance and diabetes.
Hsp60 was thus proposed to be the effector of leptin pro-
tective actions on mitochondria and acts as the integrator of
insulin signaling (Kleinridders et al. 2013).
In Drosophila, knock-down of an ETC complex I
component in the muscle induces the UPRmt and leads to
secretion of ImpL2, which non-autonomously represses
insulin signaling by binding IGF and other insulin-like
molecules (Owusu-Ansah et al. 2013). Although mito-
chondrial perturbation occurs only in the muscle, the entire
fly is smaller, demonstrating that a growth-inhibiting signal
is communicated from the muscle to all tissues. As men-
tioned above, Imp2L could hence be considered as a fly
mitokine, achieving part of the organismal adaption to the
stress by repressing systemic insulin signaling. Consistent
with this hypothesis, overexpression of Imp2L in flies
increases lifespan and enhances lysosome biogenesis,
which could contribute to mitophagy as a mechanism to
enhance mitochondrial function upon aggregate accumu-
lation (Owusu-Ansah et al. 2013).
Another line of support for the existence of a link
between the UPRmt and metabolism came from studies in
the worm where UPRmt activation was shown to lead to the
up-regulation of the expression of some glycolytic
enzymes (Nargund et al. 2012). This suggests that a met-
abolic remodeling happens concurrently with the occur-
rence of UPRmt, and energy production may shift from
OXPHOS toward glycolysis when mitochondria are
stressed.
Neurological disorders
Drosophila that are overexpressing a mutant OTC protein
develop mitochondrial dysfunction phenotypes similar to
mutants of PINK1 and Parkin (Pimenta de Castro et al.
2012), two mitophagy regulators that are found mutated in
familial forms of Parkinson’s diseases (Andreux et al.
2013). This also suggests a link between the UPRmt and
neurodegenerative disorders, associated with mitochondrial
dysfunction, such as Parkinson’s, Alzheimer’s, and Hun-
tington’s disease (de Castro et al. 2011).
Notably, the DR-driven attenuation of translation in
Dphb2 yeast (Schleit et al. 2013) (discussed above) sug-
gests that interfering with translation and mitochondrial
protein import may restore mitochondrial function in the
context of neurodegenerative diseases. In line with this
premise, repression of cytosolic translation showed bene-
ficial effects on mitochondrial function in yeast (Wang
et al. 2008) and protected Drosophila against PINK-
induced pathogenesis (Liu and Lu 2010) although the
underlying mechanisms have yet to be characterized.
Cancer
The mitochondrial stress response could also be connected
with the control of cell proliferation and cancer. Cancer is
associated with extensive remodeling of cellular metabo-
lism, required to sustain proliferation. This was first high-
lighted by the fact that cancer cells display enhanced rates
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of glycolysis and lactate production, a phenomenon called
now the ‘‘Warburg effect’’ (Warburg 1956). Although this
could suggest that mitochondria are impaired or not used in
cancer cells, it is now commonly accepted that mitochon-
drial function is necessary for cancer cell viability and
tumorigenicity (Wallace 2012). Antibiotics targeting
mitochondrial translation, such as the actinonin-based
antibiotics, have been successfully used as anti-prolifera-
tive agents (Lee et al. 2004; Skrtic et al. 2011). Part of
actinonin’s mechanism of action involves stalling of
mitochondrial ribosomes, followed by a decay of the MRPs
and of mitochondrial RNA, culminating with fractionation
of the mitochondrial network (Richter et al. 2013). This
initiates a retrograde signaling to the nucleus that results in
a block of cell proliferation. Consistent with this, actinonin
was recently shown to induce the expression of some
UPRmt genes in Burkitt’s lymphoma cells (Sheth et al.
2014). It is also tempting to speculate that anti-cancer
activity of the inhibition of cytochrome c oxidase in
complex IV, induced by treatment with the copper chelator,
tetrathiomolybdate, may involve the induction of the
UPRmt (Ishida et al. 2013), in a manner analogous to that
achieved in the worm by cco-1 RNAi targeting the com-
plex IV component, COX4 (Durieux et al. 2011). The
potential involvement of the UPRmt in these processes
would be interesting to investigate, knowing that they
likely involve a mito-nuclear protein imbalance. Although
the previous examples suggests that UPRmt activation
could be potentially be used as a cancer treatment strategy,
mitochondrial chaperones Hsp60 and Hsp10 comprised in a
signature of the statistically 67 most frequent genes
induced in tumors versus normal tissue (Rhodes et al.
2004), suggesting that the UPRmt is activated in cancer.
Thus, future studies linking cancer and the UPRmt will be
required for a better understanding.
Perspectives
Throughout this review, we have tried to give a glimpse of
the relevance of the UPRmt in mitochondrial homeostasis in
mammals. We emphasized how this pathway crucially
impacts on lifespan and fitness of lower species, such as C.
elegans and D. melanogaster. Moreover, the cell-non-
autonomous nature of the UPRmt suggests that this stress
response can be communicated among distant tissues and
determines the aging rate of the whole organism. The fact
that Mrps5 has been identified as a longevity gene in mice
(Houtkooper et al. 2013) and the lethality of Hsp60
knockout (Kleinridders et al. 2013) indicates that the
UPRmt is also essential for mitochondrial function and
whole body homeostasis in mammals. However, a more
fundamental understanding of the UPRmt pathway in
mammals is urgently required. Future research efforts will
not only need to map the tissues and the physiological
conditions in which the UPRmt is triggered but also need to
provide a deep mechanistic insight into the mammalian
UPRmt signaling and to elucidate the physiological and
pathophysiological consequences of the UPRmt activation.
The fact that mitochondrial fusion often accompanies the
UPRmt should prompt researchers to investigate how the
UPRmt communicates with and/or orchestrate the trigger-
ing of other mitochondrial, stress responses, such as fission,
fusion, mitophagy, and apoptosis (Jin and Youle 2013). On
top of that, if the homeostatic nature of the UPRmt, which
has been well established in lower species, is conserved in
mammals, modulating that this stress response might
constitute a therapeutic strategy to treat diseases charac-
terized by mitochondrial dysfunction.
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